HomeToday’s HighlightsThe Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. The Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. Today’s Highlights April 8, 2019 The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (This content is for paid subscribers. Please click here to subscribe or here to log in. Today’s Highlights Alder BioPharmaceuticals (ALDR), Amgen (AMGN), Novartis (NVS) April 8, 2019 Tweet Pin It Other Articles Sanofi Updates on Extraintestinal Pathogenic E. coli Vaccine Phase 3 Clinical Study February 13, 2025 0 Our Prohost Small Test and Anavex Life Sciences Earning Report February 12, 2025 0 Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human February 7, 2025 0 Supernus Pharmaceuticals Announced FDA Approval of product ONAPGO for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease February 5, 2025 0